CN103751310B - 一种治疗筋膜炎的中药外用制剂及其制备方法 - Google Patents
一种治疗筋膜炎的中药外用制剂及其制备方法 Download PDFInfo
- Publication number
- CN103751310B CN103751310B CN201310753567.1A CN201310753567A CN103751310B CN 103751310 B CN103751310 B CN 103751310B CN 201310753567 A CN201310753567 A CN 201310753567A CN 103751310 B CN103751310 B CN 103751310B
- Authority
- CN
- China
- Prior art keywords
- parts
- fascitis
- root
- traditional chinese
- external application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 85
- 206010016228 Fasciitis Diseases 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 39
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 34
- 235000017965 Asarum canadense Nutrition 0.000 claims abstract description 25
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 25
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 25
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 25
- 235000000385 Costus speciosus Nutrition 0.000 claims abstract description 25
- 239000004863 Frankincense Substances 0.000 claims abstract description 25
- 241000606265 Valeriana jatamansi Species 0.000 claims abstract description 25
- 235000014687 Zingiber zerumbet Nutrition 0.000 claims abstract description 25
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 24
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 24
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 23
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 20
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 20
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 18
- 235000005412 red sage Nutrition 0.000 claims abstract description 18
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 16
- 244000226566 Psoralea corylifolia Species 0.000 claims abstract description 16
- 241000131329 Carabidae Species 0.000 claims abstract description 15
- 241001116742 Drynaria Species 0.000 claims abstract description 15
- 241000951473 Schizonepeta Species 0.000 claims abstract description 15
- 241000218158 Clematis Species 0.000 claims abstract description 14
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 14
- 238000011282 treatment Methods 0.000 claims description 51
- 238000000034 method Methods 0.000 claims description 39
- 229940079593 drug Drugs 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 14
- 238000004821 distillation Methods 0.000 claims description 13
- 238000002425 crystallisation Methods 0.000 claims description 12
- 230000008025 crystallization Effects 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 11
- 239000008159 sesame oil Substances 0.000 claims description 8
- 235000011803 sesame oil Nutrition 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 238000009472 formulation Methods 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 235000013871 bee wax Nutrition 0.000 claims description 5
- 239000012166 beeswax Substances 0.000 claims description 5
- 239000002674 ointment Substances 0.000 claims description 5
- 238000007654 immersion Methods 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 88
- 230000036407 pain Effects 0.000 abstract description 85
- 230000000694 effects Effects 0.000 abstract description 64
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 59
- 201000010099 disease Diseases 0.000 abstract description 58
- 230000017531 blood circulation Effects 0.000 abstract description 22
- 239000011505 plaster Substances 0.000 abstract description 15
- 230000001717 pathogenic effect Effects 0.000 abstract description 12
- 230000002175 menstrual effect Effects 0.000 abstract description 8
- 239000000470 constituent Substances 0.000 abstract description 5
- 230000003750 conditioning effect Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 239000008280 blood Substances 0.000 description 94
- 210000004369 blood Anatomy 0.000 description 86
- 210000003734 kidney Anatomy 0.000 description 29
- 208000027418 Wounds and injury Diseases 0.000 description 26
- 210000003205 muscle Anatomy 0.000 description 26
- 206010052428 Wound Diseases 0.000 description 21
- 230000001737 promoting effect Effects 0.000 description 20
- 238000012360 testing method Methods 0.000 description 20
- 210000004185 liver Anatomy 0.000 description 19
- 239000000463 material Substances 0.000 description 18
- 238000001467 acupuncture Methods 0.000 description 17
- 230000000202 analgesic effect Effects 0.000 description 16
- 210000000988 bone and bone Anatomy 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 208000006820 Arthralgia Diseases 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 13
- 206010019233 Headaches Diseases 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- 210000001015 abdomen Anatomy 0.000 description 12
- 231100000869 headache Toxicity 0.000 description 12
- 239000000284 extract Substances 0.000 description 11
- 210000001624 hip Anatomy 0.000 description 11
- 208000005392 Spasm Diseases 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 208000025747 Rheumatic disease Diseases 0.000 description 9
- 230000003203 everyday effect Effects 0.000 description 9
- 210000003127 knee Anatomy 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 9
- 230000000552 rheumatic effect Effects 0.000 description 9
- 210000003462 vein Anatomy 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 8
- 208000019255 Menstrual disease Diseases 0.000 description 8
- 208000007101 Muscle Cramp Diseases 0.000 description 8
- 230000001154 acute effect Effects 0.000 description 8
- 230000004087 circulation Effects 0.000 description 8
- 210000003414 extremity Anatomy 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 206010000077 Abdominal mass Diseases 0.000 description 7
- 206010013935 Dysmenorrhoea Diseases 0.000 description 7
- 208000004044 Hypesthesia Diseases 0.000 description 7
- 206010037660 Pyrexia Diseases 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 208000034783 hypoesthesia Diseases 0.000 description 7
- 230000001771 impaired effect Effects 0.000 description 7
- 230000004089 microcirculation Effects 0.000 description 7
- 231100000862 numbness Toxicity 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 210000002435 tendon Anatomy 0.000 description 7
- 206010027514 Metrorrhagia Diseases 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 206010040880 Skin irritation Diseases 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 6
- 201000001881 impotence Diseases 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 239000002574 poison Substances 0.000 description 6
- 230000036556 skin irritation Effects 0.000 description 6
- 231100000475 skin irritation Toxicity 0.000 description 6
- 238000000108 ultra-filtration Methods 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 206010022000 influenza Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 230000008439 repair process Effects 0.000 description 5
- 239000002689 soil Substances 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000015271 coagulation Effects 0.000 description 4
- 238000005345 coagulation Methods 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 208000024756 faint Diseases 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000009545 invasion Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000003387 muscular Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 206010042772 syncope Diseases 0.000 description 4
- 231100000041 toxicology testing Toxicity 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 3
- 208000008967 Enuresis Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010019909 Hernia Diseases 0.000 description 3
- 240000005001 Paeonia suffruticosa Species 0.000 description 3
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 3
- 241000180649 Panax notoginseng Species 0.000 description 3
- 235000003143 Panax notoginseng Nutrition 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 206010047642 Vitiligo Diseases 0.000 description 3
- 208000004631 alopecia areata Diseases 0.000 description 3
- 230000002052 anaphylactic effect Effects 0.000 description 3
- 208000034158 bleeding Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000003859 lipid peroxidation Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 206010033675 panniculitis Diseases 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 210000000697 sensory organ Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000004304 subcutaneous tissue Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010947 Coordination abnormal Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- 206010024453 Ligament sprain Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000002740 Muscle Rigidity Diseases 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- 206010052443 Myofascitis Diseases 0.000 description 2
- 206010028748 Nasal obstruction Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000010040 Sprains and Strains Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000009692 acute damage Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000009693 chronic damage Effects 0.000 description 2
- 239000000571 coke Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- VRSRXLJTYQVOHC-YEJXKQKISA-N corydaline Chemical compound C=1([C@H]2[C@H]3C)C=C(OC)C(OC)=CC=1CCN2CC1=C3C=CC(OC)=C1OC VRSRXLJTYQVOHC-YEJXKQKISA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229960005139 epinephrine Drugs 0.000 description 2
- 230000005713 exacerbation Effects 0.000 description 2
- 210000003746 feather Anatomy 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000016290 incoordination Diseases 0.000 description 2
- 210000000281 joint capsule Anatomy 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 230000004118 muscle contraction Effects 0.000 description 2
- 230000001114 myogenic effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 208000009146 rhinoscleroma Diseases 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 235000014101 wine Nutrition 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- JBIJLHTVPXGSAM-UHFFFAOYSA-N 2-naphthylamine Chemical compound C1=CC=CC2=CC(N)=CC=C21 JBIJLHTVPXGSAM-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000427159 Achyranthes Species 0.000 description 1
- 244000000383 Allium odorum Species 0.000 description 1
- 235000018645 Allium odorum Nutrition 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 241000203233 Aspergillus versicolor Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- VRSRXLJTYQVOHC-UHFFFAOYSA-N Corydaline Natural products CC1C2C=3C=C(OC)C(OC)=CC=3CCN2CC2=C1C=CC(OC)=C2OC VRSRXLJTYQVOHC-UHFFFAOYSA-N 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- 241001489980 Eupolyphaga sinensis Species 0.000 description 1
- 206010052140 Eye pruritus Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 208000036581 Haemorrhagic anaemia Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010049949 Intercostal neuralgia Diseases 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 206010031009 Oral pain Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- SYFJYASKXNAXKC-UHFFFAOYSA-N Panaxadiol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CCC34C SYFJYASKXNAXKC-UHFFFAOYSA-N 0.000 description 1
- -1 Panaxadiol saponin Chemical class 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 241001482311 Trionychidae Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 240000000920 Typhonium flagelliforme Species 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- HVYLDJKDVOOTHV-UHFFFAOYSA-N acetic acid;2-iminoethanethiol Chemical compound CC(O)=O.CC(O)=O.SCC=N HVYLDJKDVOOTHV-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001618 algogenic effect Effects 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 210000003995 blood forming stem cell Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000005308 flint glass Substances 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000001853 liver microsome Anatomy 0.000 description 1
- 210000002311 liver mitochondria Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001185 psoriatic effect Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 208000000029 referred pain Diseases 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000001032 spinal nerve Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 210000000264 venule Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | 例数 | 痊愈 | 显效 | 有效 | 无效 | 总有效率 |
治疗组 | 40 | 21(52.5) | 12(30) | 4(10) | 3(7.5) | 92.5 |
对照组 | 40 | 15(37.5) | 11(27.5) | 6(15) | 8(20) | 80 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310753567.1A CN103751310B (zh) | 2013-12-31 | 2013-12-31 | 一种治疗筋膜炎的中药外用制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310753567.1A CN103751310B (zh) | 2013-12-31 | 2013-12-31 | 一种治疗筋膜炎的中药外用制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103751310A CN103751310A (zh) | 2014-04-30 |
CN103751310B true CN103751310B (zh) | 2016-06-08 |
Family
ID=50518737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310753567.1A Active CN103751310B (zh) | 2013-12-31 | 2013-12-31 | 一种治疗筋膜炎的中药外用制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103751310B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104189672A (zh) * | 2014-08-18 | 2014-12-10 | 史洪松 | 一种治疗筋膜炎的药膏 |
CN105412840A (zh) * | 2015-12-25 | 2016-03-23 | 青岛市第三人民医院 | 一种治疗膝关节滑囊炎的外用贴膏及其制备方法 |
CN105434782A (zh) * | 2015-12-25 | 2016-03-30 | 青岛市第三人民医院 | 一种缓解背肌筋膜炎的按摩药油及其制备方法 |
CN105943949A (zh) * | 2016-06-25 | 2016-09-21 | 丁常燕 | 一种治疗背肌筋膜炎的中药组合物 |
CN105920130A (zh) * | 2016-07-12 | 2016-09-07 | 杨高林 | 治疗足跟痛的中药制备方法及其外用膏剂 |
CN105998246A (zh) * | 2016-07-12 | 2016-10-12 | 杨高林 | 一种治疗足跟痛的中药外用膏剂及其制备方法 |
CN113499373A (zh) * | 2021-08-30 | 2021-10-15 | 陕西中医药大学附属医院 | 用于治疗足底筋膜炎的中药混悬液及应用 |
CN114177130B (zh) * | 2021-12-20 | 2023-09-29 | 李叙诺 | 肌筋膜炎外用制剂及其制备方法和应用 |
CN115737730B (zh) * | 2022-11-17 | 2023-08-22 | 南京中医药大学 | 一种用于治疗足底筋膜炎的中药组合物及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1217681C (zh) * | 2002-04-26 | 2005-09-07 | 鲍自立 | 治疗骨折、筋伤的外敷膏及其配制方法 |
CA2385271A1 (en) * | 2002-05-22 | 2003-11-22 | Chen Wang | The powder for the root-cultivation, elimination of disaster and longevity |
CN1161147C (zh) * | 2002-06-10 | 2004-08-11 | 郭好建 | 一种治疗骨关节疾病的口服中药 |
CN1923234A (zh) * | 2005-08-29 | 2007-03-07 | 刘蕾蕾 | 一种治疗骨关节疾病的中药制剂 |
CN102648953A (zh) * | 2012-03-14 | 2012-08-29 | 孙殿站 | 一种治疗风湿骨病外用药酒 |
CN103340976B (zh) * | 2013-06-18 | 2014-06-18 | 温旌国 | 一种治疗颈肩腰腿痛的药剂 |
-
2013
- 2013-12-31 CN CN201310753567.1A patent/CN103751310B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103751310A (zh) | 2014-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103751310B (zh) | 一种治疗筋膜炎的中药外用制剂及其制备方法 | |
CN100551422C (zh) | 一种治疗椎间盘突出的内服药物 | |
CN103751633B (zh) | 一种治疗下肢静脉曲张的中药组合物及其制备方法 | |
CN104306495B (zh) | 一种治疗肩周炎的中药外用制剂及其制备方法 | |
CN113456779A (zh) | 一种按摩涂抹中药药酒及其制备方法和应用 | |
CN102114217B (zh) | 一种治疗头癣的中药熏洗剂 | |
CN102872286B (zh) | 一种治疗腰间盘突出的中药组合物及其制备方法 | |
CN102626505B (zh) | 基于中草药的按摩膏及其制备方法 | |
CN109432269A (zh) | 一种中药组合物以及制备方法、用途 | |
CN102973750A (zh) | 治疗风湿、类风湿以及痛风性关节炎和颈椎病的中药 | |
CN103751710A (zh) | 一种治疗精索静脉曲张不育症的中药组合物及其制备方法 | |
CN103751309B (zh) | 一种治疗肋间神经痛的中药外用制剂及其制备方法 | |
CN102188550B (zh) | 一种治疗筋骨伤病的外用制剂 | |
CN104706953A (zh) | 一种治疗慢性子宫颈炎的中药制剂 | |
CN102579818A (zh) | 一种藏药组合物及其制备方法与应用 | |
CN103751467A (zh) | 一种治疗腰背筋膜炎的中药组合物及其制备方法 | |
CN104352737A (zh) | 一种治疗风湿性腰腿痛病的中药制剂 | |
CN102688456B (zh) | 一种治疗慢性前列腺炎的中药组合物 | |
CN105521391A (zh) | 一种补肝肾强筋骨的中药及其制备方法 | |
CN106256372A (zh) | 一种治疗慢性前列腺炎的内服药物及其制备方法 | |
CN112972611A (zh) | 一种治疗溶血性贫血的药物组合物及其应用 | |
CN104623127A (zh) | 一种用于治疗足癣的药物及其制备方法 | |
CN104338086A (zh) | 一种治疗慢性子宫内膜炎的中药灌肠剂及其制备方法 | |
CN102688391B (zh) | 一种治疗骨质疏松症的中药药酒 | |
CN116920064A (zh) | 一种治疗风湿骨病的中药配方及其加工方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160509 Address after: The city of Anshan city of Qingdao province Shandong two road 266001 No. 62 Applicant after: Zhao Yumei Address before: 266071 Shandong province Qingdao City Road No. 19 east red room unit 7 Applicant before: QINGDAO HENGBO INSTRUMENT Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Luan Zhaomin Inventor after: Sun Lifen Inventor after: Shan Lianbin Inventor before: Request for anonymity |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181221 Address after: 401120 Yubei District, Chongqing, Longxi street, Hong Jin Avenue 498, Jiale, Violet 1, 5- business. Patentee after: Chongqing Kaituo Technology Development Co.,Ltd. Address before: 266001 No. 62 A, Anshan Second Road, North District, Qingdao City, Shandong Province Patentee before: Zhao Yumei |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201116 Address after: 244000 Huayuan Road, Tongling, Anhui, No. 192 on the first floor Patentee after: Tongling Hailin Management Consulting Co.,Ltd. Address before: 401120 Jiale Ziguang Building 5-Business, 498 Hongjin Avenue, Longxi Street, Yubei District, Chongqing Patentee before: CHONGQING KAITUO TECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220928 Address after: No. 4-103-1, Social Mountain South Garden, No. 210, Zhijing Road, Zhangjiawo Town, Xiqing District, Tianjin, 300380 Patentee after: Tianjin Qingyatangya Health Consulting Co.,Ltd. Address before: 244000 1st floor, 192 Huayuan Road, Tongling City, Anhui Province Patentee before: Tongling Hailin Management Consulting Co.,Ltd. |